Physician-patient communication about complementary and alternative medical therapies: A survey of physicians caring for patients with human immunodeficiency virus infection
Mk. Wynia et al., Physician-patient communication about complementary and alternative medical therapies: A survey of physicians caring for patients with human immunodeficiency virus infection, J ALTERN C, 5(5), 1999, pp. 447-456
Objective: To examine frequency and correlates of physicians' reports of di
scussions with patients with human immunodeficiency virus (HIV) about compl
ementary and alternative medical (CAM) therapies.
Design: Mailed physician survey.
Setting: The setting was Eastern Massachusetts.
Participants: Participants included 89 physicians caring for patients with
HIV.
Measurements and Main Results: Physicians were asked how common the use of
CAM therapies was among their patients,:how useful these therapies were, ho
w often they discussed the use of CAM therapies with new and follow-up pati
ents, and whether they had used a CAM therapy themselves in the last year.
We also collected information on physicians' sociodemographic and practice
characteristics. Sixty-eight percent (89/130) of physicians responded, and
26% and 5% reported discussing CAM therapies with HIV-infected patients at
most new and follow-zip visits, respectively. Respondents' attitudes toward
the use of CAM therapies were generally positive, and they believed their
HIV-infected patients used CAM therapies more than their non-HIV infected p
atients. The majority (63%) believed that CAM therapies may be helpful for
HIV-infected patients. Thirty-six percent (36%) had used a CAM therapy them
selves in the last year. In multivariate analyses, only the belief that CAM
therapies are helpful was correlated with discussion of CAM therapies (p =
0.006). Respondents' demographic characteristics, training, personal use o
f CAM therapies, reported visit length, and satisfaction with visit length
were not associated with discussion of CAM therapies.
Conclusions: Despite awareness that their HIV-infected patients commonly us
e CAM therapies and positive attitudes towards such therapies, most of thes
e physicians did not routinely discuss CAM therapies with them. Barriers to
physician-patient communication about CAM therapies merit further investig
ation.